Bulletin
Investor Alert

New York Markets Open in:

Company Close Updates Archives | Email alerts

April 15, 2021, 4:33 p.m. EDT

Johnson & Johnson stock rises Thursday, still underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Johnson & Johnson JNJ inched 0.29% higher to $160.39 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.11% to 4,170.42 and the Dow Jones Industrial Average DJIA rising 0.90% to 34,035.99. This was the stock's second consecutive day of gains. Johnson & Johnson closed $13.26 below its 52-week high ($173.65), which the company reached on January 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. RHHVF rose 0.10% to $333.50, Merck & Co. Inc. MRK rose 0.34% to $76.66, and Pfizer Inc. PFE rose 1.16% to $37.60. Trading volume (7.5 M) eclipsed its 50-day average volume of 7.4 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Johnson & Johnson — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.